Deal Dimensions: Life lines: Life sciences M&A and the Rise of Personalized Medicine is the second in a series of reports written in collaboration by Reed Smith and Mergermarket.

Life lines explores the main drivers behind the avid pursuit for cross-border life sciences deals, the challenges faced in executing those deals, and how advances in personalized medicine may change the face of the industry.

The report is based on a survey of 100 senior decision makers in the relevant sector as well as Mergermarket deal intelligence and Reed Smith partner insight.

Read the full report.